What is Vera Therapeutics's other commercial liabilities?

Vera Therapeutics (VERA) reported other commercial liabilities of $31.24M in Q1 2026.

How has Vera Therapeutics's other commercial liabilities changed year-over-year?

Vera Therapeutics's other commercial liabilities increased by 173.1% year-over-year, from $11.44M to $31.24M.

What is the long-term trend for Vera Therapeutics's other commercial liabilities?

Over 5 years (2020 to 2025), Vera Therapeutics's other commercial liabilities has grown at a 126.0% compound annual growth rate (CAGR), from $535K to $31.56M.

Vera Therapeutics VERA Other Commercial Liabilities

Other Commercial Liabilities at other companies

Vertex PharmaceuticalsVRTX

——

Travere Therapeutics, Inc.TVTX

——

Aurinia PharmaceuticalsAUPH

——

Nektar TherapeuticsNKTR

——

Viridian Therapeutics, Inc.VRDN

——

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Operating income-$125.1M-119%

Net income-$121.0M-134%

EPS (diluted)-$1.69-109%

Balance sheet

See full

Cash & equivalents$114.4M+108%

Total debt$75.0M+37.8%

Total equity$499.7M-6.6%

Total assets$621.7M+1.9%

Cash flow

See full

Operating cash flow-$106.5M-95.8%

CapEx$23.0K-87.7%

Free cash flow-$106.5M-95.1%

Valuation

See full

Market cap$2.74B+87.5%

Enterprise value$2.7B+85.0%

Returns & leverage

See full

Return on equity-71.3%+296pp

Debt / equity0.2×0.0×

Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vera Therapeutics's other commercial liabilities?: Vera Therapeutics (VERA) reported other commercial liabilities of $31.24M in Q1 2026.
How has Vera Therapeutics's other commercial liabilities changed year-over-year?: Vera Therapeutics's other commercial liabilities increased by 173.1% year-over-year, from $11.44M to $31.24M.
What is the long-term trend for Vera Therapeutics's other commercial liabilities?: Over 5 years (2020 to 2025), Vera Therapeutics's other commercial liabilities has grown at a 126.0% compound annual growth rate (CAGR), from $535K to $31.56M.